Browse > Article
http://dx.doi.org/10.5999/aps.2019.01858

BellaGel breast implant: 6-Year results of a prospective cohort study  

Oh, Joon Seok (Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Jeong, Jae Hoon (Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Myung, Yujin (Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Oh, Jeongseok (Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Kang, Shin Hyeok (Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Park, Eonju (Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Kim, Ara (Department of Plastic and Reconstructive Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Bang, Sa Ik (Department of Plastic and Reconstructive Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Heo, Chan Yeong (Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Publication Information
Archives of Plastic Surgery / v.47, no.3, 2020 , pp. 235-241 More about this Journal
Abstract
Background This is the first clinical study conducted among Asian women using breast implants manufactured by an Asian company. Four-year data regarding the safety and efficacy of BellaGel breast implants have already been published, and we now report 6-year data. Methods This study was designed to take place over 10 years. It included 103 patients who underwent breast reconstruction or augmentation using BellaGel breast implants. The rates of implant rupture and capsular contracture were measured and analyzed to evaluate the effectiveness of the breast implant. Results At patients' 6-year postoperative visits, the implant rupture and capsular contracture rates were 1.15% and 2.30%, respectively. The implant rupture rate was 3.77% among reconstruction cases and 0% among augmentation cases. The capsular contracture rate was 5.66% among reconstruction cases and 0.83% among augmentation cases. Conclusions The 6-year data from this planned 10-year study suggest that the BellaGel cohesive silicone gel-filled breast implant is an effective and safe medical device that can be used in breast reconstruction and augmentation.
Keywords
Breast implant; Mammaplasty; Capsular contracture;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Banbury J, Yetman R, Lucas A, et al. Prospective analysis of the outcome of subpectoral breast augmentation: sensory changes, muscle function, and body image. Plast Reconstr Surg 2004;113:701-11.   DOI
2 Han J, Jeong JH, Bang SI, et al. BellaGel breast implant: 4-year results of a prospective cohort study. J Plast Surg Hand Surg 2019;53:232-9.   DOI
3 American Society of Plastic Surgeons (ASPS). 2018 Plastic surgery statistics report [internet]. Arlington Heights, IL: ASPS; c2019 [cited 2020 Feb 15]. Available from: https://www.plasticsurgery.org/news/plastic-surgery-statistics.
4 International Society of Aesthetic Plastic Surgery (ISAPS). International survey of aesthetic/cosmetic procedures performed in 2018 [internet]. Hanover, NH: ISAPS [cited 2020 Feb 15]. Available from: http://www.isaps.org.
5 Cronin TD, Gerow FJ. Augmentation mammaplasty: a new "natural feel" prosthesis. In: Broadbent TR, editor. Transactions of the Third International Congress of Plastic Surgery. Amsterdam: Excerpta Medica Foundation; 1964. p. 41-9.
6 Maxwell GP, Baker MR. Augmentation mammaplasty: general considerations. In: Spear SL, editor. Surgery of the breast. 2nd ed. Baltimore: Lippincott Williams & Wilkins; 2006. p. 1237.
7 Danino AM, Basmacioglu P, Saito S, et al. Comparison of the capsular response to the Biocell RTV and Mentor 1600 Siltex breast implant surface texturing: a scanning electron microscopic study. Plast Reconstr Surg 2001;108:2047-52.   DOI
8 Cunningham B. The Mentor study on contour profile gel silicone MemoryGel breast implants. Plast Reconstr Surg 2007;120(7 Suppl 1):33S-39S.   DOI
9 Bengtson BP, Van Natta BW, Murphy DK, et al. Style 410 highly cohesive silicone breast implant core study results at 3 years. Plast Reconstr Surg 2007;120(7 Suppl 1):40S-48S.   DOI
10 Cunningham B. The Mentor core study on silicone MemoryGel breast implants. Plast Reconstr Surg 2007;120(7 Suppl 1):19S-32S.   DOI
11 Stevens WG, Harrington J, Alizadeh K, et al. Five-year follow-up data from the U.S. clinical trial for Sientra's U.S. Food and Drug Administration-approved $Silimed^{(R)}$ brand round and shaped implants with high-strength silicone gel. Plast Reconstr Surg 2012;130:973-81.   DOI
12 Handel N, Jensen JA, Black Q, et al. The fate of breast implants: a critical analysis of complications and outcomes. Plast Reconstr Surg 1995;96:1521-33.   DOI
13 Salzberg CA, Ashikari AY, Berry C, et al. Acellular dermal matrix-assisted direct-to-implant breast reconstruction and capsular contracture: a 13-year experience. Plast Reconstr Surg 2016;138:329-37.   DOI